|
1
|
Chen Z, Zhai XF, Su YH, Wan XY, Li J, Xie
JM and Gao B: Clinical observation of cinobufacini injection used
to treat moderate and advanced primary liver cancer. Zhong Xi Yi
Jie He Xue Bao. 1:184–186. 2003.In Chinese. View Article : Google Scholar
|
|
2
|
Qin TJ, Zhao XH, Yun J, Zhang LX, Ruan ZP
and Pan BR: Efficacy and safety of gemcitabine-oxaliplatin combined
with huachansu in patients with advanced gallbladder carcinoma.
World J Gastroenterol. 14:5210–5216. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meng Z, Yang P, Shen Y, Bei W, Zhang Y, Ge
Y, Newman RA, Cohen L, Liu L, Thornton B, et al: Pilot study of
huachansu in patients with hepatocellular carcinoma, nonsmall-cell
lung cancer, or pancreatic cancer. Cancer. 115:5309–5318. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu JQ, Si N, Yang J, Zhao HY, Bian BL and
Wang HJ: Identification of bufadienolides profiling in cinobufacino
by HPLC-DAD-FT-ICR-MS method. Yao Xue Xue Bao. 49:244–248. 2014.In
Chinese. PubMed/NCBI
|
|
5
|
Wu X, Zhao H, Wang H, Gao B, Yang J, Si N
and Bian B: Simultaneous determination of eight bufadienolides in
cinobufacini injection by HPLC coupled with triple quadrupole mass
spectrometry. J Sep Sci. 35:1893–1898. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yin PH, Liu X, Qiu YY, Cai JF, Qin JM, Zhu
HR and Li Q: Anti-tumor activity and apoptosis-regulation
mechanisms of bufalin in various cancers: New hope for cancer
patients. Asian Pac J Cancer Prev. 13:5339–5343. 2012. View Article : Google Scholar
|
|
7
|
Zhu Z, Sun H, Ma G, Wang Z, Li E and Liu Y
and Liu Y: Bufalin induces lung cancer cell apoptosis via the
inhibition of PI3K/Akt pathway. Int J Mol Sci. 13:2025–2035. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Watabe M, Kawazoe N, Masuda Y, Nakajo S
and Nakaya K: Bcl-2 protein inhibits bufalin-induced apoptosis
through inhibition of mitogen-activated protein kinase activation
in human leukemia U937 cells. Cancer Res. 57:3097–3100.
1997.PubMed/NCBI
|
|
9
|
Zhu Z, Li E and Liu Y, Gao Y, Sun H, Wang
Y, Wang Z, Liu X, Wang Q and Liu Y: Bufalin induces the apoptosis
of acute promyelocytic leukemia cells via the downregulation of
survivin expression. Acta Haematol. 128:144–150. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sakaguchi S: Naturally arising
Foxp3-expressing CD25+CD4+ regulatory T cells
in immunological tolerance to self and non-self. Nat Immunol.
6:345–352. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Adachi W, Sugenoya A, Horigome N,
Takahashi C, Iida F and Nakayama J: The antitumor activity and
immunosuppressive effects of 5-fluorouracil suppositories in rectal
cancer patients. Surg Today. 22:221–225. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dunn GP, Bruce AT, Ikeda H, Old LJ and
Schreiber RD: Cancer immunoediting: From immunosurveillance to
tumor escape. Nat Immunol. 3:991–998. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Facciabene A, Motz GT and Coukos G:
T-regulatory cells: Key players in tumor immune escape and
angiogenesis. Cancer Res. 72:2162–2171. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fadul CE, Fisher JL, Gui J, Hampton TH,
Côté AL and Ernstoff MS: Immune modulation effects of concomitant
temo-zolomide and radiation therapy on peripheral blood mononuclear
cells in patients with glioblastoma multiforme. Neuro Oncol.
13:393–400. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cao Q, Wang L, Du F, Sheng H, Zhang Y, Wu
J, Shen B, Shen T, Zhang J, Li D, et al: Downregulation of
CD4+CD25+ regulatory T cells may underlie
enhanced Th1 immunity caused by immunization with activated
autologous T cells. Cell Res. 17:627–637. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Maruyama T, Kono K, Mizukami Y, Kawaguchi
Y, Mimura K, Watanabe M, Izawa S and Fujii H: Distribution of Th17
cells and FoxP3(+) regulatory T cells in tumor-infiltrating
lymphocytes, tumor-draining lymph nodes and peripheral blood
lymphocytes in patients with gastric cancer. Cancer Sci.
101:1947–1954. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cassileth B, Yeung KS and Gubili J: Herbs
and other botanicals in cancer patient care. Curr Treat Options
Oncol. 9:109–116. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim SH, Jun CD, Suk K, Choi BJ, Lim H,
Park S, Lee SH, Shin HY, Kim DK and Shin TY: Gallic acid inhibits
histamine release and pro-inflammatory cytokine production in mast
cells. Toxicol Sci. 91:123–131. 2006. View Article : Google Scholar
|
|
19
|
Scimone A and Scimone A: US sees green in
herbal supplements. Chem Mark Rep. 254:FR3–FR4. 1998.
|
|
20
|
Wu CA, Wu JJ, Tsai MJ and Chen RY:
Immunomodulatory effects of a traditional Chinese medicine,
Chi-Shie-Shuan-Bu-An-Shen-Tang, on BALB/c mice. J Ethnopharmacol.
113:300–305. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shimizu Y, Inoue E and Ito C: Effect of
the water-soluble and non-dialyzable fraction isolated from Senso
(Chan Su) on lymphocyte proliferation and natural killer activity
in C3H mice. Biol Pharm Bull. 27:256–260. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cao Y, Song Y, An N, Zeng S, Wang D, Yu L,
Zhu T, Zhang T, Cui J, Zhou C, et al: The effects of
telocinobufagin isolated from Chan Su on the activation and
cytokine secretion of immunocytes in vitro. Fundam Clin Pharmacol.
23:457–464. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang XL, Zhao GH, Zhang J, Shi QY, Guo WX,
Tian XL, Qiu JZ, Yin LZ, Deng XM and Song Y: Immunomodulatory
effects of cinobufagin isolated from Chan Su on activation and
cytokines secretion of immunocyte in vitro. J Asian Nat Prod Res.
13:383–392. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kon A, Yuan B, Hanazawa T, Kikuchi H, Sato
M, Furutani R, Takagi N and Toyoda H: Contribution of membrane
progesterone receptor α to the induction of progesterone-mediated
apoptosis associated with mitochondrial membrane disruption and
caspase cascade activation in Jurkat cell lines. Oncol Rep.
30:1965–1970. 2013.PubMed/NCBI
|
|
25
|
Kikuchi H, Yuan B, Nishimura Y, Imai M,
Furutani R, Kamoi S, Seno M, Fukushima S, Hazama S, Hirobe C, et
al: Cytotoxicity of Vitex agnuscastus fruit extract and its major
component, casticin, correlates with differentiation status in
leukemia cell lines. Int J Oncol. 43:1976–1984. 2013.PubMed/NCBI
|
|
26
|
Yoshino Y, Yuan B, Kaise T, Takeichi M,
Tanaka S, Hirano T, Kroetz DL and Toyoda H: Contribution of
aquaporin 9 and multidrug resistance-associated protein 2 to
differential sensitivity to arsenite between primary cultured
chorion and amnion cells prepared from human fetal membranes.
Toxicol Appl Pharmacol. 257:198–208. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Song MM, Fang S, Tanaka S, Sugiyama K,
Kiyomi A, Kato R, Onda K, Yuan B, Takagi N, Hu X, et al: Effects of
arsenic disulfide on proliferation, cytokine production, and
frequencies of CD4(+), CD8(+), and regulatory T cells in
mitogen-activated human peripheral blood mononuclear cells. Int
Immunopharmacol. 29:832–838. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tohyama N, Tanaka S, Onda K, Sugiyama K
and Hirano T: Influence of anticancer agents on cell survival,
proliferation, and CD4+CD25+Foxp3+
regulatory T cell-frequency in human peripheral-blood mononuclear
cells activated by T cell-mitogen. Int Immunopharmacol. 15:160–166.
2013. View Article : Google Scholar
|
|
29
|
Yu Z, Guo W, Ma X, Zhang B, Dong P, Huang
L, Wang X, Wang C, Huo X, Yu W, et al: Gamabufotalin, a
bufadienolide compound from toad venom, suppresses COX-2 expression
through targeting IKKβ/NF-κB signaling pathway in lung cancer
cells. Mol Cancer. 13:2032014. View Article : Google Scholar
|
|
30
|
Moreno Y, Banuls L, Urban E, Gelbcke M,
Dufrasne F, Kopp B, Kiss R and Zehl M: Structure-activity
relationship analysis of bufadienolide-induced in vitro growth
inhibitory effects on mouse and human cancer cells. J Nat Prod.
76:1078–1084. 2013. View Article : Google Scholar
|
|
31
|
Qi F, Li A, Inagaki Y, Kokudo N, Tamura S,
Nakata M and Tang W: Antitumor activity of extracts and compounds
from the skin of the toad Bufo bufo gargarizans Cantor. Int
Immunopharmacol. 11:342–349. 2011. View Article : Google Scholar
|
|
32
|
Qi F, Li A, Zhao L, Xu H, Inagaki Y, Wang
D, Cui X, Gao B, Kokudo N, Nakata M, et al: Cinobufacini, an
aqueous extract from Bufo bufo gargarizans Cantor, induces
apoptosis through a mitochondria-mediated pathway in human
hepatocellular carcinoma cells. J Ethnopharmacol. 128:654–661.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Moreno Y, Banuls L, Katz A, Miklos W,
Cimmino A, Tal DM, Ainbinder E, Zehl M, Urban E, Evidente A, Kopp
B, et al: Hellebrin and its aglycone form hellebrigenin display
similar in vitro growth inhibitory effects in cancer cells and
binding profiles to the alpha subunits of the
Na+/K+-ATPase. Mol Cancer. 12:332013.
View Article : Google Scholar
|
|
34
|
Tian HY, Wang L, Zhang XQ, Zhang DM, Wang
Y, Liu JS, Jiang RW and Ye WC: New bufadienolides and
C23 steroids from the venom of Bufo bufo gargarizans.
Steroids. 75:884–890. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang DM, Liu JS, Deng LJ, Chen MF, Yiu A,
Cao HH, Tian HY, Fung KP, Kurihara H, Pan JX, et al: Arenobufagin,
a natural bufadienolide from toad venom, induces apoptosis and
autophagy in human hepatocellular carcinoma cells through
inhibition of PI3K/Akt/mTOR pathway. Carcinogenesis. 34:1331–1342.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Deng LJ, Peng QL, Wang LH, Xu J, Liu JS,
Li YJ, Zhuo ZJ, Bai LL, Hu LP, Chen WM, et al: Arenobufagin
intercalates with DNA leading to G2 cell cycle arrest
via ATM/ATR pathway. Oncotarget. 6:34258–34275. 2015.PubMed/NCBI
|
|
37
|
Tang N, Shi L, Yu Z, Dong P, Wang C, Huo
X, Zhang B, Huang S, Deng S, Liu K, et al: Gamabufotalin, a major
derivative of bufadienolide, inhibits VEGF-induced angiogenesis by
suppressing VEGFR-2 signaling pathway. Oncotarget. 7:3533–3547.
2016.
|
|
38
|
Fink SL and Cookson BT: Apoptosis,
pyroptosis, and necrosis: Mechanistic description of dead and dying
eukaryotic cells. Infect Immun. 73:1907–1916. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Peterson RA: Regulatory T-cells: Diverse
phenotypes integral to immune homeostasis and suppression. Toxicol
Pathol. 40:186–204. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Iriyama N, Yoshino Y, Yuan B, Horikoshi A,
Hirabayashi Y, Hatta Y, Toyoda H and Takeuchi J: Speciation of
arsenic trioxide metabolites in peripheral blood and bone marrow
from an acute promyelocytic leukemia patient. J Hematol Oncol.
5:12012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Iriyama N, Yuan B, Yoshino Y, Hatta Y,
Horikoshi A, Aizawa S, Takeuchi J and Toyoda H: Aquaporin 9, a
promising predictor for the cytocidal effects of arsenic trioxide
in acute promyelocytic leukemia cell lines and primary blasts.
Oncol Rep. 29:2362–2368. 2013.PubMed/NCBI
|
|
42
|
Hu XM, Tanaka S, Onda K, Yuan B, Toyoda H,
Ma R, Liu F and Hirano T: Arsenic disulfide induced apoptosis and
concurrently promoted erythroid differentiation in
cytokine-dependent myelodysplastic syndrome-progressed leukemia
cell line F-36p with complex karyotype including monosomy 7. Chin J
Integr Med. 20:387–393. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hu XM, Yuan B, Tanaka S, Zhou Q, Onda K,
Toyoda H and Hirano T: Involvement of oxidative stress associated
with glutathione depletion and p38 mitogen-activated protein kinase
activation in arsenic disulfide-induced differentiation in HL-60
cells. Leuk Lymphoma. 55:392–404. 2014. View Article : Google Scholar
|
|
44
|
Early Breast Cancer Trialists'
Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal
therapy for early breast cancer on recurrence and 15-year survival:
An overview of the randomised trials. Lancet. 365:1687–1717. 2005.
View Article : Google Scholar : PubMed/NCBI
|
